StockData
AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

AIBOTICS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About Aibotics

Medicinal Chemicals & Botanical Products, SIC 2833

Aibotics, Inc. develops wellness and healthcare technologies, focusing on consumer robotics and the research of psychedelics for mental health treatments. The company's consumer product offerings include the Phill Robot, an artificial-intelligence-controlled massage robot designed for home use, and Milkyway, an automated smart storage refrigerator designed for preserving breast milk. In its therapeutic activities, the company promotes studies on natural and synthetic molecules to treat conditions like depression and addiction, while sourcing naturally derived psilocybin active pharmaceutical ingredients. Its target customers and partners include retail consumers, nursing rooms, hospitals, research institutions, universities, and pharmaceutical manufacturers.

The company operates virtually without owning physical real estate or leasing office facilities. Its corporate headquarters or specific physical operational facilities are not specified in the text, as it conducts business through a fully remote model. While aiming to supply active pharmaceutical ingredients to international jurisdictions that permit psilocybin, the company presently operates with a single subsidiary in Florida.

Summary of the business section of Aibotics's latest annual report, written by StockData.

Company profile

Company

Legal name
AIBOTICS, INC.
Founded
2000
Headquarters
Heyburn, ID
Address
480 22nd Street 83336
Phone
(208) 677-2020
Employees
1, Dec 31, 2020
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
Fruci & Associates II, PLLC, Spokane, Washington

Stock & identifiers

Ticker
AIBT
Exchange
OTC
Shares outstanding
850M, Aug 19, 2026
Public float
$1.37M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
2-for-1, May 1, 2014
SEC CIK
1763329
EIN
87-0645794

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Benjamin Nathaniel KaplanCEO, Director95,250,000
Benjamin KaplanCEO, Director20,250,000
Mark CroskeryDirector10,016,912

Employees

Headcount reported in annual reports

“We currently have one employee, who is also our chief executive officer.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 16, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 14, 2026Late filingNotification of late filing
May 15, 2026Late filingNotification of late filing
Mar 31, 2026Late filingNotification of late filing
Nov 14, 2025Late filingNotification of late filing
Aug 14, 2025Late filingNotification of late filing
May 15, 2025Late filingNotification of late filing
Mar 31, 2025Late filingNotification of late filing
Dec 17, 2024Name changeName changed from Mycotopia Therapies, Inc. to AIBOTICS, INC.
Aug 14, 2024Late filingNotification of late filing
Apr 1, 2024Late filingNotification of late filing
Mar 28, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 5, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 14, 2023Late filingNotification of late filing
May 15, 2023Late filingNotification of late filing
May 17, 2022Late filingNotification of late filing
Apr 5, 2022Late filingNotification of late filing
Mar 31, 2022Late filingNotification of late filing
Nov 17, 2021Late filingNotification of late filing
Aug 16, 2021Late filingNotification of late filing
May 19, 2021Name changeName changed from 20/20 Global, Inc. to Mycotopia Therapies, Inc.
May 19, 2021Late filingNotification of late filing
Apr 1, 2021Late filingNotification of late filing
Mar 30, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 20, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 14, 2020Late filingNotification of late filing
May 15, 2020Late filingNotification of late filing
Aug 15, 2019Late filingNotification of late filing